The role of PGRMC1 in hepatic cholesterol homeostasis
PGRMC1 在肝脏胆固醇稳态中的作用
基本信息
- 批准号:8210363
- 负责人:
- 金额:$ 5.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAffectBile AcidsBindingCardiovascular DiseasesCellsCellular MembraneCholesterolCholesterol HomeostasisCytochrome P450DevelopmentDietary intakeEmbryoEnzymesExcretory functionHemeHepaticHumanHydroxymethylglutaryl-CoA reductaseInvestigationKidneyKnowledgeLanosterolLeadLipidsLipoproteinsLiverMembrane ProteinsMetabolismMixed Function OxygenasesOrganPharmaceutical PreparationsPrevalencePreventiveRoleSerumSignal TransductionSteroidsStructureTestingTherapeuticbasecardiovascular disorder riskfluidityheme-binding proteinnovelnovel strategiesnovel therapeutic interventionparticlepreventpublic health relevancesmall hairpin RNAsterol homeostasis
项目摘要
DESCRIPTION (provided by applicant): Cholesterol is essential for the proper structure and fluidity of cellular membranes and for the function of membrane proteins. Cholesterol also serves as a precursor of steroids, oxysterols, and bile acids. These metabolites serve important functions in signal transduction and, in the case of bile acids, lipid solubilization. Elevated serum cholesterol levels are associated with increased risk for cardiovascular disease (CVD). A clear understanding of how cells regulate cholesterol synthesis will accelerate the development of novel preventive and therapeutic approaches to CVD. In humans, the supply of cholesterol in the body is controlled by several factors including dietary intake, synthesis, storage, and excretion. Key regulators of cholesterol synthesis and metabolism are the cytochrome P450 monooxygenases. The synthesis of cholesterol from lanosterol requires the P450 enzyme, Cyp51A1. Our lab recently identified the heme-binding protein PGRMC1 as a binding partner and positive regulator of Cyp51A1 and demonstrated that shRNA knockdown of PGRMC1 in human embryonic kidney (HEK) 293 cells disrupts cholesterol synthesis. PGRMC1 and Cyp51A1 are both highly expressed in the liver-an essential organ in cholesterol metabolism. Based on these findings, I hypothesize that PGRMC1 is a critical regulator of hepatic cholesterol synthesis and is necessary for maintaining systemic cholesterol homeostasis. My aims are to: (1) Determine the function of PGRMC1 in hepatic cholesterol synthesis and (2) Investigate the role of PGRMC1 in systemic sterol homeostasis. Together, these investigations will help elucidate the function of PGRMC1 in cholesterol homeostasis.
PUBLIC HEALTH RELEVANCE: Adults with high serum cholesterol levels have an increased risk of cardiovascular disease. This project will determine the function of the novel cytochrome P450 regulator PGRMC1 in hepatic and systemic cholesterol homeostasis. A clear understanding of PGRMC1 function will increase our knowledge of how cholesterol homeostasis is achieved and may reveal new therapeutic approaches for lowering serum cholesterol levels and reducing the prevalence of cardiovascular disease.
描述(由申请人提供):胆固醇对于细胞膜的适当结构和流动性以及膜蛋白的功能至关重要。胆固醇也是类固醇,氧蛋白酶和胆汁酸的前体。这些代谢产物在信号转导中起重要功能,而在胆汁酸的情况下,脂质溶解化。血清胆固醇水平升高与心血管疾病(CVD)的风险增加有关。对细胞如何调节胆固醇合成的清晰了解将加速新型预防和治疗方法的CVD。在人类中,体内胆固醇的供应受到饮食摄入,合成,储存和排泄的几个因素的控制。胆固醇合成和代谢的关键调节剂是细胞色素P450单加氧酶。 lanosterol的胆固醇的合成需要P450酶CYP51A1。我们的实验室最近将血红素结合蛋白PGRMC1确定为CYP51A1的结合伴侣和阳性调节剂,并证明了人类胚胎肾脏(HEK)293个细胞中PGRMC1的shRNA敲低破坏了胆固醇的合成。 PGRMC1和CYP51A1在胆固醇代谢中的肝脏基本器官中都高度表达。根据这些发现,我假设PGRMC1是肝胆固醇合成的关键调节剂,对于维持全身胆固醇的稳态是必不可少的。我的目的是:(1)确定PGRMC1在肝胆固醇合成中的功能,(2)研究PGRMC1在全身固醇稳态中的作用。总之,这些研究将有助于阐明PGRMC1在胆固醇稳态中的功能。
公共卫生相关性:血清胆固醇水平高的成年人患心血管疾病的风险增加。该项目将确定新型细胞色素P450调节剂PGRMC1在肝和系统性胆固醇稳态中的功能。对PGRMC1功能的清晰了解将增加我们对如何实现胆固醇稳态的了解,并可能揭示出新的治疗方法来降低血清胆固醇水平并降低心血管疾病的患病率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rita Thomas Brookheart其他文献
Rita Thomas Brookheart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rita Thomas Brookheart', 18)}}的其他基金
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
位点 1 蛋白酶在骨骼肌代谢和运动耐力调节中的作用
- 批准号:
10421052 - 财政年份:2019
- 资助金额:
$ 5.22万 - 项目类别:
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
位点 1 蛋白酶在骨骼肌代谢和运动耐力调节中的作用
- 批准号:
10186796 - 财政年份:2019
- 资助金额:
$ 5.22万 - 项目类别:
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
Site-1 蛋白酶在骨骼肌代谢和运动耐力调节中的作用
- 批准号:
10630296 - 财政年份:2019
- 资助金额:
$ 5.22万 - 项目类别:
The role of PGRMC1 in hepatic cholesterol homeostasis
PGRMC1 在肝脏胆固醇稳态中的作用
- 批准号:
8402604 - 财政年份:2011
- 资助金额:
$ 5.22万 - 项目类别:
The role of PGRMC1 in hepatic cholesterol homeostasis
PGRMC1 在肝脏胆固醇稳态中的作用
- 批准号:
8060758 - 财政年份:2011
- 资助金额:
$ 5.22万 - 项目类别:
Regulation of Lipotoxicity by the non-coding RNA gadd7
非编码 RNA gadd7 的脂毒性调节
- 批准号:
7231127 - 财政年份:2006
- 资助金额:
$ 5.22万 - 项目类别:
Regulation of Lipotoxicity by the non-coding RNA gadd7
非编码 RNA gadd7 的脂毒性调节
- 批准号:
7294862 - 财政年份:2006
- 资助金额:
$ 5.22万 - 项目类别:
相似国自然基金
胆汁酸通过LXR-β调节肝内2型固有淋巴细胞的数量和功能影响NASH相关肝纤维化的进程研究
- 批准号:82300706
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“肠道菌群—胆汁酸-TGR5/HIF-1α”途径探讨人参皂苷Rb1及丹酚酸B组合影响肠道巨噬细胞代谢重编程缓解糖尿病小鼠代谢炎症的机制研究
- 批准号:82305033
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
肠道菌-胆汁酸调控FXR信号通路影响内脏脂肪堆积的性别差异
- 批准号:82300976
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
胆汁酸-FXR-FGF轴介导舍内氨气暴露影响生长猪肌肉蛋白质沉积的机制
- 批准号:32302806
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SLC25A47调控胆汁酸合成对肝脏胆固醇稳态的影响与机制研究
- 批准号:82370581
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Bile acid receptor signaling in retinopathy of prematurity
早产儿视网膜病变中胆汁酸受体信号传导
- 批准号:
10568100 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
The role of sphingosine kinase 2 in mitochondrial dysfunction and NAFLD
鞘氨醇激酶 2 在线粒体功能障碍和 NAFLD 中的作用
- 批准号:
10607244 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic insufficiency.
一种新型高度稳定的胰酶替代疗法,可改善胰腺功能不全患者的预后。
- 批准号:
10543210 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
The Ability of Glyphosate to Impair Metabolic Homeostasis Via the Gut Microbiome and Metabolites
草甘膦通过肠道微生物组和代谢物损害代谢稳态的能力
- 批准号:
10707920 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Obstructive sleep apnea, the microbiome and cardiovascular disease
阻塞性睡眠呼吸暂停、微生物组和心血管疾病
- 批准号:
10544020 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别: